CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
Preparation with Spirulina +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03535974
NCT03535974N/ACompleted

Evaluation of the Efficacy of a Supplement With Spirulina for Amelioration of Benign Thyroid Nodules

Fundatia Bio-Forum·interventional·Posted May 24, 2018·Updated May 19, 2020

In Brief

A clinical study evaluating Preparation with Spirulina and Placebo for Benign Thyroid Nodule. Completed, enrolled 38 participants across 1 site.

Detailed Summary

Clinical trial with a double-blind, placebo-controlled, crossover design; enrolls approximately 30 euthyroid patients with benign thyroid nodules, who will receive for 6 weeks a spirulina-based supplement, and for another 6 weeks placebo. Thyroid ecography will be performed three times for each patient, and blood tests including TSH, free T4, free T3 and ceruloplasmin/Copper will also be performed 3 times for each patient. It is expected that a decrease in the thyroid nodules occurs with the supplement administration. Compared with placebo there will be a decrease of at least 20% in the volume or the largest diameter of the nodules during the 6-week administration of the supplement.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesRomania
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 24, 2018
Enrollment StartMay 15, 2018
Primary CompletionDec 20, 2018
Study CompletionDec 21, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.1 years ago

Interventions

Preparation with Spirulinadietary

Preparation with Spirulina to ameliorate the size of benign thyroid nodules

Placebodietary

Placebo administration for 6 weeks bid